ARGUN AKCAKANAT to Proto-Oncogene Proteins c-mdm2
This is a "connection" page, showing publications ARGUN AKCAKANAT has written about Proto-Oncogene Proteins c-mdm2.
Connection Strength
0.299
-
Combined MEK/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterations. Sci Rep. 2022 01 24; 12(1):1248.
Score: 0.154
-
First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models. Breast Cancer Res. 2021 03 04; 23(1):29.
Score: 0.145